Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

This study has been terminated.
(Too few participants recruited within timeframe)
Sponsor:
Collaborators:
BioMarin Pharmaceutical
University of Missouri-Columbia
Northwestern University
Oregon Health and Science University
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00827762
First received: January 21, 2009
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)